an Indian biopharmaceutical company
India's Biocon developing its own version of Wegovy, clinical trial likely next year
reuters.com/business/healthcare-pharmaceuticals/indias-biocon-developing-its-own-version-wegovy-clinical-trial-likely-next-year-2024-04-18/
Quick Glance: Biocon Developing Own Version of Wegovy, Plans Clinical Trial
- Indian pharmaceutical company Biocon is working on developing its own version of Novo Nordisk's popular Wegovy and is likely to conduct a clinical trial next year to enter the growing weight-loss drug market.
- Biocon's CEO, Siddharth Mittal, has expressed the company's intention to develop semaglutide, the active ingredient in Wegovy, for the Indian market, even if it requires a clinical trial.
- Biocon aims to introduce generic versions of weight-loss drugs in emerging markets such as Brazil, Mexico, and Saudi Arabia before the patent for semaglutide expires in those countries in 2026.
- The company is striving to obtain a waiver on clinical trials from Indian regulators and submit bioequivalence studies to demonstrate the effectiveness of their version of semaglutide. Biocon is making significant investments in generics research and development, including peptides for weight-loss drugs.
Biocon leads generic race for blockbuster weight loss drugs as patents set to expire soon
financialexpress.com/healthcare/pharma-healthcare/biocon-leads-generic-race-for-blockbuster-weight-loss-drugs-as-patents-set-to-expire-soon/3449767/
From Gita Gopinath to Kiran Mazumdar-Shaw: 6 influential women impacting society: In today's dynamic world, women are increasingly taking center stage ...
financialexpress.com/lifestyle/from-gita-gopinath-to-kiran-mazumdar-shaw-6-influential-women-impacting-society/3417271/
Here's a compilation of interesting numbers that matter!
Read the #NewsInNumbers on Mint app every weekday: mintiphone.page.link/Hy8V #RealEstate #Deloitte #NTPC #BoAt #Biocon ... Show more #Fuel #Energy #TataPower #Delhi #India
Stocks in News: आज HCL Tech, Zomato, Axis Bank, Biocon सहित इन शेयरों में रहेगा एक्शन, इंट्राडे में रखें नजर
hindi.financialexpress.com/business-news/hcl-tech-vodafone-idea-zomato-axis-bank-biocon-among-top-buzzing-stocks-today-3-april-2024-4450449
India's Biocon to sell branded formulations business to Eris Lifesciences for $150 mln
reuters.com/markets/deals/indias-biocon-sell-branded-formulations-business-eris-lifesciences-150-mln-2024-03-14/
Stocks to Watch, March 15: BPCL, IOC, IIFL Finance, Paytm, YES Bank, Biocon: Stocks to Watch on Friday, March 15, 2024: The Centre has reduced prices of petrol ...
business-standard.com/markets/news/stocks-to-watch-today-march-15-bpcl-ioc-iifl-finance-paytm-yes-bank-biocon-124031500096_1.html
Stocks to watch: Paytm, Tata Group, Airtel, Biocon, Suven, Vedanta, L&T: Top Stocks to watch Today, March 1, 2024: L&T has commissioned its first hydrogen ...
business-standard.com/markets/news/stocks-to-watch-paytm-tata-group-airtel-biocon-suven-vedanta-l-t-124030100083_1.html
Biocon receives a penalty of over Rs 3 crore in GST related issues: Biocon Ltd on Friday said it has been imposed a penalty of over Rs 3 crore over GST-related ...
business-standard.com/companies/news/biocon-receives-a-penalty-of-over-rs-3-crore-in-gst-related-issues-124022300635_1.html
In next 4-5 years, we aim capex of Rs 1,500 cr: Biocon's Siddharth Mittal: Siddharth Mittal outlines the growth strategies and challenges ahead
business-standard.com/companies/interviews/in-next-4-5-years-we-aim-capex-of-rs-1500-cr-biocon-s-siddharth-mittal-124021100457_1.html
Paid articlePaid
Kiran Mazumdar-Shaw calls pink tax 'shameful gender bias', asks women to do this: According to the World Economic Forum, the disparity between the pricing of ...
hindustantimes.com/trending/kiran-mazumdar-shaw-calls-pink-tax-shameful-gender-bias-asks-women-to-do-this-101710304186334.html
Biocon gets over Rs 3 crore penalty over GST related issues: There is no material impact on the financials, operations or other activities of the company ...
financialexpress.com/business/industry-biocon-gets-over-rs-3-crore-penalty-over-gst-related-issues-3403690/
Biocon posts net profit at Rs 660 crore in Dec quater: Biotech firm Biocon on Thursday reported a consolidated net profit of Rs 660 crore for the third quarter ...
financialexpress.com/business/industry-biocon-posts-net-profit-at-rs-660-crore-in-dec-quater-3388600/
Biocon posts net profit at Rs 660 crore in Dec quater: Biotech firm Biocon on Thursday reported a consolidated net profit of Rs 660 crore for the third quarter ...
financialexpress.com/business/industry-biocon-posts-net-profit-at-rs-660-crore-in-dec-quater-3388600/
7 Female Indian Entrepreneurs Paving The Way For the Future: These trailblazers are not just shattering glass ceilings, they're building empires that ...
indiatimes.com/lifestyle/sunny-side-up/womens-day-indian-female-entrepreneurs-628287.html
Stocks in News: आज ICICI Bank, Adani Enterprises, Maruti, Biocon सहित इन शेयरों में रहेगा एक्शन, इंट्राडे में रखें नजर
hindi.financialexpress.com/business-news/icici-bank-adani-enterprises-maruti-tata-motors-aurobindo-pharma-biocon-among-top-buzzing-stocsk-today-4159964
7 Empowering Women To Inspire You Mid Week: Sometimes motivation can feel like a distant memory. But fear not! To reignite your fire and fuel your spirit ...
indiatimes.com/lifestyle/self/7-empowering-women-to-inspire-you-mid-week-626994.html
Stocks in News: आज LIC, Zomato, Biocon, PFC, Paytm सहित इन शेयरों में रहेगा एक्शन, रखें नजर
hindi.financialexpress.com/business-news/lic-kalyan-jewellers-zomato-biocon-pfc-patanjali-foods-paytm-among-top-buzzing-stocks-today-9-february-2024-3665035
Oral cancer task force’s guidelines for Head & Neck cancer recognised among 13 worldwide clinical practice guidelines
financialexpress.com/healthcare/news-healthcare/oral-cancer-task-forces-guidelines-for-head-neck-cancer-recognised-among-13-worldwide-clinical-practice-guidelines/3384571/
Despite protests, BMRCL MD Anjum Parvez says ‘Biocon’ prefix cannot be removed from Hebbagodi Metro station name
indianexpress.com/article/cities/bangalore/despite-protests-bmrcl-md-anjum-parvez-biocon-prefix-cannot-remove-hebbagodi-metro-station-name-9103432/
Saluting Icons, Celebrating Dreams: A Republic Day Ode to Entrepreneurial Pioneers! 🇮🇳
Swipe left to relive the remarkable journeys of Dhirubhai Ambani - ... Show more
Nirmala Sitharaman to Kiran Mazumdar-Shaw: Introducing the leading women shaping India’s landscape in 2023
financialexpress.com/lifestyle/nirmala-sitharaman-to-kiran-mazumdar-shaw-introducing-the-leading-women-shaping-indias-landscape-in-2023/3350212/
Investing half a billion dollar in our generics business: Biocon MD & CEO: Biocon CEO Siddharth Mittal: Debt-reduction plans are progressing a tad slowly ...
business-standard.com/companies/interviews/investing-half-a-billion-dollar-in-our-generics-business-biocon-md-ceo-123121500948_1.html
Paid articlePaid Not evaluating any divestment options for API business, says Biocon: Biotechnology major Biocon on Friday said it is not evaluating divestment options for its ...
business-standard.com/companies/news/not-evaluating-any-divestment-options-for-api-business-says-biocon-123121500902_1.html
In a first, metro’s monthly ridership crosses 2 crore; up 30% in just a year: In a first, metro’s monthly ridership crosses
2 crore; up 30% in just a year
deccanherald.com/india/karnataka/bengaluru/in-a-first-metro-s-monthly-ridership-crosses-2-crore-up-30-in-just-a-year-2842161
Stocks in News: फोकस में रहेंगे SBI, NBCC, Biocon, IRCTC समेत ये स्टॉक, इंट्राडे में दिखेगा एक्शन
hindi.financialexpress.com/business-news/sbi-ultratech-cement-nbcc-biocon-irctc-uno-minda-mm-among-top-buzzing-stocks-today-14-december-2023-2022938
Biosimilars growth pushes Biocon Q2 PAT rises 168% to Rs 126 crore: Biocon Quarter 2: On a sequential basis, the company exhibited a 1.15 per cent increase in ...
business-standard.com/companies/results/biocon-q2-results-net-profit-zooms-over-two-fold-revenue-up-49-123111000947_1.html
Biocon Biologics targets top three biosimilar spot: Shreehas Tambe: Biocon biologics: The opportunity ahead of us is massive because over the next 10 odd years ...
business-standard.com/companies/interviews/biocon-aims-to-become-a-top-three-biosimilar-players-in-world-tambe-123111300860_1.html
Paid articlePaid Eris up 8% as it plans to acquire nephro, derma units of Biocon Biologics: The deal consideration is Rs 366 crore inclusive of working capital ...
business-standard.com/markets/news/eris-up-8-as-it-plans-to-acquire-nephro-derma-units-of-biocon-biologics-123110900300_1.html
Grapevine: Biocon, Shriram Finance plan to sell units; Footpath Ventures eyes IPL franchise
vccircle.com/grapevinebiocon-shriram-finance-plan-to-sell-units-footpath-ventures-eyes-ipl-franchise
4 Indians In Forbes' Most Powerful Women List, Nirmala Sitharaman At 32: Three other Indian women named in the Forbes list are Roshni Nadar Malhotra ...
ndtv.com/india-news/4-indians-in-forbes-most-powerful-women-list-nirmala-sitharaman-at-32-4637687
Union Finance Minister #NirmalaSitharaman , HCL Corporation Chairperson #RoshniNadar Malhotra, Steel Authority Of India Chairperson #SomaMondal and #Biocon Executive Chairperson #KiranMazumdar -Shaw ... Show more #Indians #Forbes #MostPowerfulWomen tinyurl.com/ystw9xb6
Zerodha's Nikhil Kamath names three Bengaluru entrepreneurs who inspired him to donate majority of his wealth | Mint
livemint.com/companies/zerodhas-nikhil-kamath-names-three-bengaluru-entrepreneurs-who-inspired-him-to-donate-majority-of-his-wealth-11699438867852.html
Paid articlePaid 16th edition of CPHI & PMEC India Expo to be held from November 28-30; over 1,500 leading pharma exhibitors to participate
financialexpress.com/healthcare/pharma-healthcare/16th-edition-of-cphi-pmec-india-expo-to-be-held-from-november-28-30-over-1500-leading-pharma-exhibitors-to-participate/3319081/
Biocon jumps 4% on the back of strong Q2 performance: The stock had shed 16 per cent in Samvat 2079. So far in 2023, the stock has declined 9 per cent as against ...
business-standard.com/markets/news/biocon-jumps-4-on-the-back-of-strong-q2-performance-123111200577_1.html
Biocon Biologics appoints Kedar Upadhye as new chief financial officer: Current CFO, MB Chinappa will take on a strategic finance role at Biocon Group
business-standard.com/companies/people/biocon-biologics-appoints-kedar-upadhye-as-new-chief-financial-officer-123101900691_1.html
Bengaluru provided content for Trevor Noah's future shows: Kiran Mazumdar-Shaw: Biocon chief Kiran Mazumdar-Shaw said Bengaluru city's “shambolic” state has ...
hindustantimes.com/cities/bengaluru-news/bangalores-shambolic-state-has-provided-enough-content-for-trevor-noah-s-future-shows-says-kiran-mazumdarshaw-101696301595268.html
India's Biocon names Peter Bains as group CEO: Indian drugmaker Biocon Ltd (BION.NS) on Monday appointed Peter Bains as the group's chief executive officer ...
reuters.com/business/healthcare-pharmaceuticals/indias-biocon-names-peter-bains-group-ceo-2023-09-18/
#ForbesIndiaRichList | Biocon's Kiran Mazumdar Shaw has a net worth of $2.52 billion. Her rank dropped 16 places from 76 last year to 92 this year www.forbesindia.com/lists/rich-list-2023/
Biocon slips 4% after USFDA asks for corrective measures at Malaysian unit: The USFDA has determined the inspection classification as 'OAI' (Official Action ...
business-standard.com/markets/news/biocon-slips-4-after-usfda-asks-for-corrective-measures-at-malaysian-unit-123101800241_1.html
On track to integrate major part of Viatris’ acquired biosimilars business this fiscal: Kiran Mazumdar-Shaw
financialexpress.com/business/industry/on-track-to-integrate-major-part-of-viatris-acquired-biosimilars-business-this-fiscal-kiran-mazumdar-shaw/3227965/
Stocks in News: आज फोकस में रहेंगे TCS, L&T, Tech Mahindra, Tata Power, Coal India समेत ये स्टॉक, इंट्राडे में दिखेगा एक्शन
hindi.financialexpress.com/business-news/ril-infosys-hul-icici-bank-union-bank-hdfc-bank-vedanta-among-top-buzzing-stocks-today-21-july-2023/3064130/
Hinduja Brothers to Kiran Mazumdar-Shaw: Here are the richest Indian business tycoons in UK; Take a look at their net worth and lifestyle
financialexpress.com/lifestyle/from-the-hinduja-brothers-to-kiran-mazumdar-shaw-here-are-the-richest-indian-business-tycoons-in-uk-take-a-look-at-their-net-worth-and-lifestyle/3224380/
"I think this is an important event. I do hope that we get unanimous passage of the bill in the Lok Sabha becasue I think this is the reservation bill ... Show more #WomenReservationBill
Quick Glance: India: Women's Reservation Bill Passed - Slow Progress Expected
- Indian Parliament approves bill reserving one-third of seats in lower house and state assemblies for women.
- Implementation will be delayed until after the next census and redrawing of constituency boundaries, which is expected to take several years.
Biocon may list biosimilars business by 2025 first half - CEO: Indian biopharmaceutical company Biocon Ltd (BION.NS) is planning to list its biosimilars business ...
reuters.com/markets/deals/biocon-may-list-biosimilars-business-by-2025-first-half-ceo-2023-08-11/
Quick Glance: Biocon to List Biosimilars Business by 2025 - CEO
- Biocon Biologics, a subsidiary of Biocon Ltd, focuses on manufacturing biosimilars in the United States and Europe.
- The biologics business may be listed on the stock market after the second half of 2024 and is expected to take place in the first half of 2025.
- Biocon acquired the biosimilar business of a US-based company last year.
- Revenue in the biosimilars business more than doubled to 20.15 billion Indian rupees in the last quarter.
#StocksToWatch | Kotak Bank, RIL, Bajaj Auto, Infosys, ONGC, IDFC First
Read here: www.livemint.com/market/stock-market-news/stocks-to-watch-kotak-bank-ril-bajaj-auto-infosys-ongc-idfc-first-11693786301960.html
Kiran Mazumdar-Shaw spoke to NDTV about Women's Reservation Bill being brought in the parliament. She said, "The moment is historic and is a very ... Show more
Who is Siddharth Mittal: The CEO of Biocon, founded by Kiran Mazumdar Shaw; know about his career, education, and net worth
financialexpress.com/lifestyle/who-is-siddharth-mittal-the-ceo-of-biocon-founded-by-kiran-mazumdar-shaw-know-about-his-career-education-and-net-worth/3201355/
Biocon Biologics gains EU approval for Aflibercept biosimilar, YESAFILI: Biocon Biologics: According to market research firm IQVIA, Aflibercept generated about ...
business-standard.com/companies/news/biocon-biologics-gains-eu-approval-for-aflibercept-biosimilar-yesafili-123092000847_1.html
Stocks to Watch on Aug 14: Adani Ports, Nykaa, Raymond, PSU Banks, Biocon: Stocks to watch on August 14, 2023: Balrampur Chini, Delta Corp, Indiabulls Housing ...
business-standard.com/markets/news/stocks-to-watch-today-aug-14-adani-ports-nykaa-raymond-psu-banks-biocon-123081400077_1.html
Biocon Biologics ahead of plan in integrating biosimilar biz of Viatris: BBL is actively working on raising funds from private equity investors to retire part of ...
business-standard.com/companies/news/biocon-biologics-ahead-of-plan-in-integrating-biosimilar-biz-of-viatris-123081100679_1.html
Nikhil Kamath and Kiran Mazumdar Shaw together pledge ₹50 lakh to charity | Mint
livemint.com/news/india/nikhil-kamath-and-kiran-mazumdar-shaw-together-pledge-50-lakhs-to-charity-11691047198844.html
Paid articlePaid Biocon Biologics eyes a third of FY24 revenue from emerging markets: Biocon Biologics: BBL, which launched Hulio, a biosimilars version of Abbvie's blockbuster ...
business-standard.com/companies/news/emerging-mkts-to-contribute-one-third-of-biocon-biologics-revenues-in-fy24-123070600745_1.html
India's Biocon Q1 profit falls on higher R&D spending: India's Biocon (BION.NS) on Thursday posted a 29.8% fall in June-quarter profit, hurt by increased ...
reuters.com/business/healthcare-pharmaceuticals/indias-biocon-q1-profit-falls-higher-rd-spending-2023-08-10/
Quick Glance: Biocon's Q1 Profit Declines in First Quarter due to Increased R&D Spending
- Consolidated net profit for the first quarter until June 30 amounted to 1.01 billion rupees, compared to 1.44 billion rupees in the previous year.
- Revenue from generic drugs increased by 15.3% to 7 billion rupees, while research services saw a 25.4% growth to 8.08 billion rupees.
- The global biosimilars market is expected to reach $74 billion by 2030, as projected by McKinsey.
Biocon Biologics’ biosimilar of Humira is now available in United States: Biocon Biologics, which recently announced its acquisition of Viatris’ global ...
financialexpress.com/healthcare/pharma-healthcare/biocon-biologics-biosimilar-of-humira-is-now-available-in-united-states/3154596/
Stocks in News: आज फोकस में रहेंगे SBI, REC, LTIMindtree, Biocon, Minda समेत ये स्टॉक, इंट्राडे में दिखेगा एक्शन
hindi.financialexpress.com/business-news/ril-mm-tata-motors-bajaj-auto-indusind-bank-spicejet-among-top-buzzing-stocks-today-4-july-2023/3058805/
#StocksToWatch | Here are top stocks that could be in focus today!
Read here: www.livemint.com/market/stock-market-news/stocks-to-watch-ril-idfc-idfc-first-hma-agro-bajaj-finance-bom-11688429860515.html
Advent may rope in new investor for Bharat Serums with neat valuation markup: VCCircle is India leading source Latest Indian Financial News,Startup Funding ...
vccircle.com/adventmay-rope-in-new-investor-for-bharat-serums-with-neat-valuation-markup
The Indian Pharma Industry Can Become A Significant Value Creator: Kiran Mazumdar-Shaw - Forbes India
forbesindia.com/article/leadership/the-indian-pharma-industry-can-become-a-significant-value-creator-kiran-mazumdarshaw/85465/1
Nikhil Kamath to donate 50% of wealth to Bill Gates-Warren Buffet founded 'The Giving Pledge' | Mint
livemint.com/companies/people/zerodha-co-founder-nikhil-kamath-to-donate-50-of-wealth-to-bill-gates-warren-buffet-founded-the-giving-pledge-11686052523908.html
Paid articlePaid F&O Strategy for Biocon: HDFC Securities recommends a Bull Spread: The stock price of Biocon has broken out on the daily chart with higher volumes where it ...
business-standard.com/markets/news/f-o-strategy-for-biocon-hdfc-securities-recommends-a-bull-spread-123061600105_1.html
IRB Infra gains 2%, Gold shines on, Biocon receives GMP certification. A short 🧵 on the top trending stories of the hour.
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics